Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.

Tsiachristas A. et al, (2022), BMC Cancer, 22

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Dixon P. et al, (2022), Genetics in Medicine

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Dixon P. et al, (2022), Genetics in Medicine

Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.

Benger JR. et al, (2022), Health Technol Assess, 26, 1 - 158

The net benefit of personalised medicine: A systematic literature review and regression analysis.

Vellekoop H. et al, (2022), Value in Health

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article

Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Pollard S. et al, (2022), Value Health

Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.

Yang M. et al, (2022), Health Econ

Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer

Lim E. et al, (2022), NEJM Evidence, 1

WHAT IS THE NET ADDED VALUE OF PERSONALISED MEDICINE? A SYSTEMATIC LITERATURE REVIEW

Vellekoop H. et al, (2022), VALUE IN HEALTH, 25, S75 - S75

Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets.

Buckell J. et al, (2021), Health Econ

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

100,000 Genomes Project Pilot Investigators None. et al, (2021), N Engl J Med, 385, 1868 - 1880

Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice.

Borek AJ. et al, (2021), Implement Sci Commun, 2

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment

MORRELL E., (2021), PLoS Medicine

What aspects of illness influence public preferences for healthcare priority setting? A discrete choice experiment in the UK

MORRELL E. et al, (2021), PharmacoEconomics

Does bariatric surgery reduce future hospital costs? A propensity score-matched analysis using UK Biobank Study data.

Wu T. et al, (2021), Int J Obes (Lond)

Clinical utility of whole-genome sequencing in precision oncology.

Rosenquist R. et al, (2021), Semin Cancer Biol

Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Pollard S. et al, (2021), Eur J Hum Genet

Cost-effectiveness of the i-gel Supraglottic Airway Device compared to Tracheal Intubation During Out-of-Hospital Cardiac Arrest: Findings from the AIRWAYS-2 Randomised Controlled Trial

Stokes EA. et al, (2021), Resuscitation

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Pollard S. et al, (2021), European Journal of Human Genetics

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?